Teva launches generic Protonix, ups '07 EPS forecast
640367
Israel's Teva Pharmaceutical  Industries Ltd   raised its 2007 earnings  outlook following the launch of its generic version of Wyeth's   ulcer drug Protonix.
634295
PRINCETON, N.J., June 15  /PRNewswire/ -- Next Inning Technology Research ( http://www.nextinning.com/ ), a subscription service focused on semiconductor and technology stocks, announced it has published updated outlooks for Clearwire , EchoStar Communications , DirecTV , and Color Kinetics .
439056
The generics drugmaker forecasts its 2008 financials.
441225
PepsiCo Inc. reaffirmed on Thursday its 2007 earnings forecast of at least $3.30 per share.
587421
Investors kept their eye on makers of generic pharmaceuticals Monday with news that Mylan Laboratories Inc. received Food and Drug Administration approval to market a generic version of a Novartis AG hypertension
160050
Drugmaker Alpharma Inc. on Friday said it launched its generic version of Pfizer Inc.&#39;s Neurontin for the treatment of epilepsy.
653146
roundup Plus: The company also expects to meet or exceed analyst estimates...Salesforce.com reports subscriber surge...RealNetworks signs up Red Flag Linux.
768745
Alexander Linden, a prominent Gartner Research analyst will be talking about the future later this week in Cannes, France. Smart Web was held ahead of this week&#39;s ITXpo symposium, an annual event held to identify the future of technology.
362513
Company Expects to Achieve Profitability in 2005 MARTINSRIED, Germany, Oct. 28 /CNW/ - MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment, TecDAX) today reported financial results for the first ...
721890
By John Gittelsohn, The Orange County Register, Calif.  Dec. 6--Emulex Corp., a Costa Mesa maker of computer networking and  server connections, announced plans to buy back up to $150 million in stock  over the next two years.
410983
Plus:  EarthLink trims outlook...AT&#38;T posts $7.1 billion loss...Lucent sees first profitable year since 2000...EMC issues sunny report.
167166
The moment Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA; TASE:TEVA) investors feared but also impatiently awaited has arrived.
269144
NEW YORK, September 7 (New Ratings) - Yellow Roadway Corp (YELL.NAS) has reportedly raised its 3Q earnings forecast. The US-based trucking company has raised its EPS projections for 3Q from $1.
211418
PMC-Sierra, Inc. (Nasdaq:PMCS) today announced the PM8310 TEMUXÂ®  336, the industry's most integrated and  scalable framer solution for next generation voice, wireless and router  platforms.
539663
Regulatory News:  Technip (Paris:TEC) (NYSE:TKP) (ISIN:FR0000131708) has been awarded by  CEPSA a lumpsum engineering, procurement and construction (EPC)  contract, worth approximately &#8364;60 million, for  a hydrogen plant to be built at the Huelva refinery, Spain.
734267
By Thomas Ginsberg, The Philadelphia Inquirer  Jan. 31--Here is something you may not hear every day: The drug giant Wyeth said yesterday that it was "surprised" to hear that it is about to face generic competition on its $216 million heart drug Inderal LA.
196912
Nonbinding offers for the generics  business of Merck KGaA , worth at least 4 billion  euros ($5.3 billion), are due on Monday, a source close to the  sale process told Reuters, confirming a newspaper report.